Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q4 2017 · 10-K
Revenue$621.30M$621.30M+8.7% vs Q4 2016 Net Income$82.70M$82.70MN/M vs Q4 2016 EPS Diluted$2.75$2.75N/M vs Q4 2016 Gross Profit$345,200,000+9.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flowderived$69,365,000−26.8% Free Cash Flowderived$43,297,000−12.8% Margins · derivedGross margin55.6%+0.5 pt vs Q4 2016
Operating margin7.4%+12.3 pt vs Q4 2016
Net margin13.3%+16.6 pt vs Q4 2016
ended Dec 31, 2017 · filed Apr 16, 2018 · 106 d after period end